NeoGenomics Inc. (NEO)
NASDAQ
Real-time Data
01:30 PM
Day's Range
16.3752 wk Range
6.38Overview - NEO - NeoGenomics Inc.
Key Statistics
Valuation
Enterprise Value
2.45B
P/E (Trailing)
‪-20.16‬
P/E (Forward)
‪48.85‬
PEG Ratio
‪0.19‬
Price / Sales (TTM)
‪2.81‬
Price / Book
‪2.73‬
EV / EBITDA
‪101.12‬
Profitability
Gross Margin
‪45.56%‬
Profit Margin
‪-6.77%‬
Operating Margin
‪-4.84%‬
Return on Assets
‪-1.88%‬
Return on Equity
‪-6.32%‬
Ownership
Shares Outstanding
127.91M
Float
117.03M
Short % of Shares Outstanding
‪14.16%‬
Held by Insiders
‪2.06%‬
Held by Institutions
‪115.51%‬
Price stats
Beta
‪1.73‬
50-Day Avg
‪14.52‬
200-Day Avg
‪11.33‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
12 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NEO - NeoGenomics Inc.
Peers - NEO - NeoGenomics Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- NEONASDAQNeoGenomics Inc.2.04BMarket Cap+60.85%52-week change-18.99P/E (Trailing)‪-6.77%‬Profit Margin
- NTRANASDAQNATERA INC (Common Stock) – ticker 45E47.23BMarket Cap+50.52%52-week change-220.14P/E (Trailing)‪-7.10%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.43.33BMarket Cap-16.52%52-week change38.86P/E (Trailing)‪25.03%‬Profit Margin
- ILMNNASDAQIllumina, Inc.33.70BMarket Cap+55.77%52-week change41.01P/E (Trailing)‪18.33%‬Profit Margin
- GHNASDAQGuardant Health Inc.22.13BMarket Cap+61.54%52-week change-49.67P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings Inc.17.13BMarket Cap+23.58%52-week change36.41P/E (Trailing)‪17.66%‬Profit Margin
- ICICLRNASDAQICON plc13.38BMarket Cap-0.84%52-week change264.97P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - NEO - NeoGenomics Inc.
About
NeoGenomics Inc. is a leading cancer diagnostics company specializing in oncology genetics testing and information services. It offers one of the most comprehensive menus of oncology-focused tests worldwide, including next-generation sequencing (NGS), comprehensive genomic profiling, and advanced assays like RaDaR ST…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
